Ekf Diagnostics Holding PLC (LON:EKF)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $32.98 and traded as low as $30.95. Ekf Diagnostics shares last traded at $30.95, with a volume of 38,145 shares trading hands.
The business’s fifty day moving average price is GBX 32.96 and its 200 day moving average price is GBX 32.98. The company has a quick ratio of 1.34, a current ratio of 1.81 and a debt-to-equity ratio of 2.67. The firm has a market capitalization of $144.18 million and a PE ratio of 13.80.
About Ekf Diagnostics (LON:EKF)
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Africa, and internationally. It offers DiaSpect Tm, an hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a centrifuge that provides a hematocrit reading for six blood samples.
Featured Article: What is the definition of arbitrage?
Receive News & Ratings for Ekf Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekf Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.